The Postprandial-to-Fasting Serum C-Peptide Ratio is a Predictor of Response to Basal Insulin-Supported Oral Antidiabetic Drug(s) Therapy: A Retrospective Analysis.
Pan-Wei MuDe-Zhao LiuYing LinDong LiuFan ZhangYong-Jun ZhangShuo LinLin-Qin WangMan-Man WangJiong ShuLong-Yi ZengYan-Ming ChenPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2018)
A higher 2 h-PCP/FCP ratio and a lack of previous insulin treatment increase the likelihood of BOT success.